Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Kite Announces Plans to Build a New Manufacturing Industry
Kite announces plans to build industryleading cell therapy manufacturing capabilities with a new viral vector facility in Oceanside, California
Lonza Announces to Expand HPAPI Development and Manufacturing Capacity
Lonza announced an expansion of Highly Potent API HPAPI capabilities from development to commercial scale manufacturing, including formulation and delivery
Tergus Pharma to Build a New Commercial Manufacturing Facility with Great Point Partners
Tergus Pharma partners with Great Point Partners to build a new commercial manufacturing facility A 100,000 square feet new expansion will provide comprehensive services from development through manufacturing and will become a Contract Development and Manufacturing Organisation, or CDMO
Aldevron Breaks Ground to Build 14-Acre Gene Therapy Manufacturing Campus
Aldevron announces its plans to build 14acre gene therapy manufacturing campus at its headquarters in Fargo
Intertek Expands Pharmaceutical Services
Intertek announced an expansion of the pharmaceutical services for specialist inhalation and nasal product development for biologics in Melbourne, near Cambridge
WuXi Biologics Announced Construction of a 69 million Integrated Manufacturing Center in Southwest China
WuXi Biologics commenced construction of a new 69 million integrated manufacturing centre for innovative biologics at Chengdu, Southwest China
Thermo Fisher Invests US$ 50 million to Expand Bioproduction Capabilities
Thermo Fisher Scientific announced that it is investing US$50 million in its global bioproduction capabilities
Intertek to Expand Pharmaceutical Services Facility in Melbourn
Intertek announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, through the acquisition of a new 20,000 sq ft facility
Merck Announces Expansion of Manufacturing Facility with US$165 million investment
Merck announced an investment of US$165 million in its manufacturing site at Aubonne, Switzerland, to expand its production of biotech medicines
MaSTherCell SA Announces New Manufacturing Facility in Belgium
MaSTherCell SA announced new manufacturing facility in Belgium for cell and gene therapy products The company has signed a lease agreement for a 5,700m2 61,354ft facility located in Belgium The new facility will become a stateoftheart manufacturing and production site designed for latestage and commercially approved cell and gene therapy products
